Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update

(NasdaqGM:KYMR), Reported positive KT-621 (STAT6) Phase 1 healthy volunteer data surpassing Kymera's target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) patients on track to report data in 4Q25 Doses selected for KT-621 Phase 2b trials in AD and asthma, which are […]

Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results

(NasdaqGM:APGE), Positive 16-week data from APEX Phase 2 Part A met all primary and key secondary endpoints for APG777, a potentially best-in-class anti-IL-13 antibody, in moderate-to-severe atopic dermatitis APEX Part A testing every 3- or 6-month maintenance dosing, a significant improvement versus standard of care which is dosed every two weeks, is ongoing with 52-week

Sionna Therapeutics Reports Second Quarter 2025 Financial Results

Sionna Therapeutics Reports Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 Announced positive Phase 1 data for SION-719 and SION-451 demonstrating both first-in-class NBD1 stabilizers were generally well tolerated and exceeded pharmacokinetic targets Initiation of Phase 2a proof-of-concept trial of SION-719 as an add-on to standard of care in cystic fibrosis patients is on

Rocky Shore Gold Announces Non-Brokered Private Placement

(CNSX:RSG.CN),(Pinksheets:CNOBF),(PinkSheets:CNOBF), TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Rocky Shore Gold Ltd. (“Rocky Shore” or the “Company”) (CSE: RSG) announces that it is undertaking a non-brokered private placement (the “Offering”) to raise aggregate gross proceeds of up to $1,500,000 through the sale of a combination of units (“Units”) at a price of $0.05 per Unit

FDA Clears IND for SEED Therapeutics’ RBM39 Degrader ST-01156

FDA Clears IND for SEED Therapeutics' RBM39 Degrader ST-01156 GlobeNewswire August 11, 2025 • First Patient Dosing Expected in Q1 2026 • Clinical Trial to Prioritize Biomarker-Selected RBM39-Dependent Cancers KING OF PRUSSIA, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) — SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rational molecular glue degraders for historically undruggable

CECO Environmental Announces Upcoming Investor Conferences

(NASDAQ:CECO), ADDISON, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announces that CECO management will participate at the following investor conferences: August 18, 2025 – The 14th Annual Needham Virtual Industrial Tech, Robotics, &

NorthWest Closes Second Tranche of Flow Through Financing and Completes Hard Dollar Placement

NorthWest Closes Second Tranche of Flow Through Financing and Completes Hard Dollar Placement GlobeNewswire August 11, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — NorthWest Copper Corp. (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce that further

And the Winners Are: HR Executive and HR Tech Announce 2025 Top HR Products of the Year

WEST PALM BEACH, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) — Dedicated to honoring HR excellence, the editors at HR Executive and the team at HR Tech today revealed the winners of the Top HR Products of the Year. The industry's most prestigious award, the annual competition recognizes notable technological advancements from the past year, focused

Asante Signs Definitive Agreements to Unlock Approximately $500M of Financing Proceeds

Asante Signs Definitive Agreements to Unlock Approximately $500M of Financing Proceeds GlobeNewswire August 11, 2025 VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) — Asante Gold Corporation (CSE: ASE | GSE: ASG | FRANKFURT:1A9 | OTCQX: ASGOF) (“Asante” or the “Company”) is pleased to announce that it has entered into the key definitive agreements (the

Interpublic Partners with Aaru to Leverage AI-Powered Predictive Simulations to Accelerate, Scale and Optimize Marketing

(NYSE:IPG), New York, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG), a global leader in marketing solutions, today announced a first-of-its-kind strategic partnership with Aaru, a cutting-edge AI and technology company specializing in predictive simulations for human behavior. This collaboration empowers Interpublic and its agencies to leverage Aaru's state-of-the-art multi-agent infrastructure and

Scroll to Top